MarketPeel
Chief R&D Officer
Thu, Feb 1, 2024
Feb 1
received an award in FATE
450,000 shares @ $0.00
New position
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
FATEFATE THERAPEUTICS INC
HealthcareBiotechnology
1D0.00%
1W-4.67%
1M+1.66%
3M
6M
1Y

Recent insider activity at FATE

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback